Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Definium Therapeutics, Inc.

Definium Therapeutics Announces New Employee Inducement Grants

March 09, 2026

From Definium Therapeutics, Inc.

Via Business Wire

Tickers DFTX

Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates

February 26, 2026

From Definium Therapeutics, Inc.

Via Business Wire

Tickers DFTX

Definium Therapeutics to Participate at Upcoming Investor Conferences

February 24, 2026

From Definium Therapeutics, Inc.

Via Business Wire

Tickers DFTX

Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026

February 19, 2026

From Definium Therapeutics, Inc.

Via Business Wire

Tickers DFTX

Definium Therapeutics Announces New Employee Inducement Grants

February 02, 2026

From Definium Therapeutics, Inc.

Via Business Wire

Tickers DFTX

Definium Therapeutics Appoints Roger Adsett to Board of Directors

January 29, 2026

From Definium Therapeutics, Inc.

Via Business Wire

Tickers DFTX

Definium Therapeutics Announces New Employee Inducement Grants

January 26, 2026

From Definium Therapeutics, Inc.

Via Business Wire

Tickers DFTX

Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care

January 20, 2026

From Definium Therapeutics, Inc.

Via Business Wire

Tickers DFTX

Definium Therapeutics Common Shares to Trade under New Nasdaq Ticker Symbol “DFTX” Effective January 15, 2026

January 13, 2026

From Definium Therapeutics, Inc.

Via Business Wire

MindMed Rebrands to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026

January 12, 2026

From Definium Therapeutics, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.